Phenanthroline

Phenanthroline

SCHEMBL4296938

COc1c(F)c(F)c([Cu])c(F)c1F.c1cnc2c(c1)ccc1cccnc12

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.50
CCR1 P32246 4/20 0.50
CCR8 P51685 4/20 0.50
CCR5 P51681 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
MAPT P10636 3/20 0.50
KDM4E B2RXH2 2/20 0.50
HTT P42858 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
MMP2 P08253 2/20 0.50
TSHR P16473 2/20 0.50
GMNN O75496 1/20 0.50
TP53 P04637 1/20 0.50
HSP90AA1 P07900 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
MMP9 P14780 1/20 0.50
ALOX15 P16050 1/20 0.50
NFKB1 P19838 1/20 0.50
MMP8 P22894 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4138169 0.88 LMNA (0.59) LMNACCR1CCR8CCR5SMN1; SMN2
SCHEMBL4700675 0.77 LMNA (0.52) LMNACCR1CCR8CCR5SMN1; SMN2
SCHEMBL14768504 0.71 LMNA (0.59) LMNACCR1CCR8CCR5SMN1; SMN2
Phenanthroline SCHEMBL29367277 0.71 CCR1 (1.00) LMNACCR1CCR8CCR5SMN1; SMN2
Phenanthroline SCHEMBL29354015 0.71 CCR1 (1.00) LMNACCR1CCR8CCR5SMN1; SMN2
Phenanthroline SCHEMBL8312 0.71 CCR1 (1.00) LMNACCR1CCR8CCR5SMN1; SMN2
Phenanthroline SCHEMBL8845760 0.71 CCR1 (1.00) LMNACCR1CCR8CCR5SMN1; SMN2
SCHEMBL4539236 0.70 LMNA (0.52) LMNACCR1CCR8CCR5SMN1; SMN2
Phenanthroline SCHEMBL9046756 0.69 CCR1 (0.84) LMNACCR1CCR8CCR5SMN1; SMN2
Phenanthroline SCHEMBL18113452 0.69 CCR1 (0.84) LMNACCR1CCR8CCR5SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8952207-B2 Copper-catalyzed C—H bond arylation THE UNIVERSITY OF HOUSTON SYSTEM (US) 2015-02-10 US disclosed
US-20090076266-A1 COPPER-CATALYZED C-H BOND ARYLATION THE UNIVERSITY OF HOUSTON SYSTEM (US) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076266-A1 COPPER-CATALYZED C-H BOND ARYLATION AOC2, AOC3, DBH LMNA 4869/4885CCR1 132/4885CCR8 778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.